FST Life Sciences, Inc. — Form D/A
FST Life Sciences, Inc. of ANN ARBOR, MI, a company, filed a Form D amendment with the SEC on 2010-09-14. The offering totals $1.3M, of which $1.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-09-14
- Form: D/A
- Accession: 0001400452-10-000005
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.3M
- Amount sold: $1.1M
- Remaining: $259K
- Minimum investment: $10K
- Investors: 9
- Date of first sale: 2010-06-03
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-143634
Issuer
- Name: FST Life Sciences, Inc.
- CIK: 0001400452
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2006
- Address: 201 S. MAIN STREET, ANN ARBOR, MI, 48104
- Phone: 216-702-0094
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Michael Bunker | Director | Ottawa Hills, OH |
| Thomas Holleran | Director | Ann Arbor, MI |
| Andrew McColm | Director | MIAMI, FL |
| Thomas Holleran | Executive Officer | Ann Arbor, MI |
Other filings by this issuer (1)
More